Drug interactions
Betrixaban + Eptifibatide
Severity: Major
Betrixaban and Eptifibatide: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Combining a glycoprotein IIb/IIIa inhibitor with a factor Xa inhibitor raises the risk of serious bleeding. Both agents impair hemostasis through different pathways.
What this interaction means in plain words
Betrixaban and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive pharmacodynamic effects: factor Xa inhibition by betrixaban plus inhibition of platelet aggregation by eptifibatide.
What to do
Avoid the combination where possible, or limit its duration and monitor closely for bleeding and falls in hemoglobin. Reassess the need for both agents daily.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Betrixaban and Eptifibatide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Eptifibatide
Frequently asked questions
Can I take Betrixaban with Eptifibatide?
MediHelp rates the interaction as major. Betrixaban and Eptifibatide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Combining a glycoprotein IIb/IIIa inhibitor with a factor Xa inhibitor raises the risk of serious bleeding. Both agents impair hemostasis through different pathways.
How serious is the interaction between Betrixaban and Eptifibatide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible, or limit its duration and monitor closely for bleeding and falls in hemoglobin. Reassess the need for both agents daily.
What other medicines interact with Eptifibatide?
MediHelp also lists interactions of Eptifibatide with, for example, Abrocitinib, Acalabrutinib, Acetylsalicylic acid. The full list is on the Eptifibatide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
